NFKB1 and cancer: Alongside NSAIDs, anti-inflammatory and anti-cancer activities have been recognised for a number of natural products, glucocorticoids, immunosuppressants, or inhibitors of other pathways, directly affecting the NF-κB induction or signalling cascade, the translocation of NF-κB to the nucleus, the DNA binding of the dimers or their interactions with the transcriptional machinery [3].